Vimarsana
Biggest News Aggregation in the World

Page 18 - Mkango News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mkango. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mkango Today - Breaking & Trending Today

Completion of £1.5 Million Investment by CoTec Into - Vimarsana News

Completion of £1.5 Million Investment by CoTec Into

Highlights CoTec invests £1.5 million (C$2.5 million) in Mkango’s subsidiary, Maginito Limited (“Maginito”), for a 10% equity interest and...

CoTec Holdings Corp.: Completion of £1.5 Million Investment by CoTec into Maginito Limited and Co-Operation Agreement Signed for Development of Rare Earth Technologies in The United States - Vimarsana News

CoTec Holdings Corp.: Completion of £1.5 Million Investment by CoTec into Maginito Limited and Co-Operation Agreement Signed for Development of Rare Earth Technologies in The United States

HighlightsCoTec invests £1.5 million (C$2.5 million) in Mkango's subsidiary, Maginito Limited ("Maginito"), for a 10% equity interest and John Singleton, Chief Operating Officer of CoTec, has been appointed

Small-cap movers: Creo Medical Group plc's rollercoaster ride gets investors cheering - Vimarsana News

Small-cap movers: Creo Medical Group plc's rollercoaster ride gets investors cheering

It was a bad week at the lower echelons of the property market, which made for a dour five trading days for junior stocks which bucked the wider positive...

SMALL CAP MOVERS: Kanabo surges amid hopes for inhaler approval - Vimarsana News

SMALL CAP MOVERS: Kanabo surges amid hopes for inhaler approval

Purplebricks tumbled nearly 15% after putting itself up for sale following a profit warning. But Kanabo surged on hopes that its cannabis inhaler will gain European CE approval.

SMALL CAP MOVERS: Kanabo surges amid hopes for inhaler approval - Vimarsana News

SMALL CAP MOVERS: Kanabo surges amid hopes for inhaler approval

Purplebricks tumbled nearly 15% after putting itself up for sale following a profit warning. But Kanabo surged on hopes that its cannabis inhaler will gain European CE approval.